In No. 11 of the Cannabis Commerce + Chemistry Podcast, host Curt Robbins from Higher Learning LV and co-hosts John Bailey from the Mindset Genesis and Dena Putnam from Leafwize Naturals are joined by guest Hart Steinfeld from SNDL in Calgary, Canada to discuss a 2021 research study pertaining to the potential efficacy of cannabis for Parkinson’s disease.
Guest Steinfeld shares his views of this important study and how he approaches the topic of employee education, particularly at the retail level where it is rigorously regulated by Canadian authorities, at SNDL as Manager of Cannabis Education and Training.
This weekly 30-minute podcast is targeted at cannabis and hemp industry professionals and is strategically free of profanity and crude dialog.
Study Summary: Cannabis for Parkinson’s Disease
For this week’s episode, the following article was the topic of discussion that was shared with participants prior to the capture of the episode: Study Summary: Cannabis in Parkinson’s Disease
A February 2021 peer-reviewed research study entitled “Cannabis in Parkinson’s Disease: The Patients’ View” that was published in the Journal of Parkinson’s Disease and conducted in Germany had the stated objective of assessing the Parkinson’s patient community’s “perception of medical cannabis and patients’ experience with medical cannabis.”
The design of this study was that of a questionnaire-based survey that “evaluated general knowledge and interest in medical marijuana, as well as the frequency, modalities, efficacy, and tolerability of application.”
What is it?
Parkinson’s disease is “a progressive disorder that affects the nervous system and the parts of the body controlled by the nerves.” It reports that the onset of symptoms begins slowly and that it may be “a barely noticeable tremor in just one hand.”
One of the major symptoms is tremors, but “the disorder may also cause stiffness or slowing of movement.”
Other symptoms include: a lack of facial expression, reduced mobility, and speech that “may become soft or slurred.”
Because it is progressive in nature, Parkinson’s disease symptoms “worsen as [the] condition progresses over time.” Unfortunately, there is no known cure for Parkinson’s.
A total of 1,348 questionnaires (surveys) were collected and analyzed. Of these survey responses:
51 percent of participants were aware of the legality of medical marijuana in Germany.
28 percent were aware that various consumption avenues (“routes of administration”) are available including smoking, vaporization, edibles, sublingual tinctures, transdermal patches, and others).